A multibillion-dollar investment in synthetic 5-MeO-DMT underscores growing optimism about its antidepressant potential.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...

A recent study published in the journal Neuropsychopharmacology provides evidence that a single dose of the psychedelic drug ...

A least 13 kids consumed mushroom-laced chocolate at the East Orange YMCA summer camp. Here's what to know about the ...

At a Profs and Pints talk, trauma therapist Whitney Marris explains how psychedelics harness neuroplasticity to treat mental ...

SAN ANTONIO — San Antonio's mayor believes the Alamo City could serve as a hub for innovation, especially when it comes to ...

For decades, psychedelics were seen as dangerous, illegal and off-limits. Now, one of the world's biggest drugmakers is ...

For half a century, psychedelic medicine was the field serious money would not touch. That ended this morning. Eli Lilly and ...

The greatest therapeutic effects of psychedelics appear to occur long after the drug is gone. New research suggests they ...

CNBC pharma reporter Angelica Peebles broke down the biggest psychedelics deal in Big Pharma history on July 16, 2026. She ...

Eli Lilly is making its biggest move yet into the rapidly evolving field of psychedelic medicine, acquiring clinical-stage ...

The Minnesota Legislature in 2023 created the Psychedelic Medicine Task Force, which was charged with evaluating whether we should expand access to psychedelic medicines here to help address the ...